secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sotera Health Co (SHC)
CIK:        0001822479
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001822479-26-000028
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Sotera Health reports Q1 2026 results and announces CEO transition
------------------------------------------------------------------

- Q1 net revenues up 10.0% (6.5% constant currency); net income $27M vs loss $13M in prior year.
- Adjusted EBITDA increased 10.5% (6.9% constant currency); Adjusted EPS $0.18, up 29%.
- Michael Petras appointed Executive Chairman; Alton Shader named CEO effective May 26, 2026.
- Reaffirmed 2026 outlook: net revenue growth 5.0%-6.5% and Adj. EBITDA growth 5.5%-7.0% constant currency.
- Added independent directors Rich Kyle and Ken Krause to Board; public float ~90%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822479/000182247926000028/0001822479-26-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822479/000182247926000028/shc-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001822479-26-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer